Evidence map›Paper›PMID 24898351›Full record

ArticleBrain : a journal of neurology2014

Endoplasmic reticulum stress in spinal and bulbar muscular atrophy: a potential target for therapy.

Karli Montague, Bilal Malik, Anna L Gray, Albert R La Spada, Michael G Hanna, Gyorgy Szabadkai, Linda Greensmith

Open access · hybridAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Targeted Molecular Therapies for SBMA.Journal of molecular neuroscience : MN · 2016
    Review
  15. The Role of the Protein Quality Control System in SBMA.Journal of molecular neuroscience : MN · 2016
    Review
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Karli Montague1 Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, Queen Square, London, WC1N 3BG, UK2 MRC Centre for Neuromuscular Diseases, Institute of Neurology, UCL, Queen Square, London, WC1N 3BG, UK.
Bilal Malik1 Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, Queen Square, London, WC1N 3BG, UK2 MRC Centre for Neuromuscular Diseases, Institute of Neurology, UCL, Queen Square, London, WC1N 3BG, UK.
Anna L Gray1 Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, Queen Square, London, WC1N 3BG, UK2 MRC Centre for Neuromuscular Diseases, Institute of Neurology, UCL, Queen Square, London, WC1N 3BG, UK.
Albert R La Spada3 Department of Paediatrics, University of California San Diego, La Jolla, CA 92093, USA4 Department of Cellular & Molecular Medicine and Neurosciences, University of California San Diego, La Jolla, CA 92093, USA5 Division of Biological Sciences, University of California San Diego, La Jolla, CA 92093, USA6 Institute for Genomic Medicine, University of California San Diego, La Jolla, CA 92093, USA7 Sanford Consortium for Regenerative Medicine, University of California San Diego, La Jolla, CA 92093, USA8 Rady Children's Hospital, San Diego, CA 92123, USA.
Michael G Hanna2 MRC Centre for Neuromuscular Diseases, Institute of Neurology, UCL, Queen Square, London, WC1N 3BG, UK9 Department of Molecular Neuroscience, Institute of Neurology, UCL, Queen Square, London, WC1N 3BG, UK.
Gyorgy Szabadkai10 Cell and Developmental Biology Department, UCL, Gower Street, London, WC1E 6BT, UK11 Department of Biomedical Sciences, University of Padua and CNR Neuroscience Institute, Padua, Italy.
Linda Greensmith1 Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, Queen Square, London, WC1N 3BG, UK2 MRC Centre for Neuromuscular Diseases, Institute of Neurology, UCL, Queen Square, London, WC1N 3BG, UK l.greensmith@ucl.ac.uk.
University College London · GBNational Hospital for Neurology and Neurosurgery · GBUniversity of California, San Diego · USUniversity of Padua · IT

Funding

MODELS OF SBMA MOTOR NEURON DEGENERATIONR01NS041648 · NINDS · UNIVERSITY OF WASHINGTON · PI LA SPADA, ALBERT R · 2001 to 2014
$4.5M
Medical Research Council MR/K000608/1NINDS NIH HHS R01 NS041648Wellcome Trust
6 · The paper itself

Abstract

Spinal and bulbar muscular atrophy is an X-linked degenerative motor neuron disease caused by an abnormal expansion in the polyglutamine encoding CAG repeat of the androgen receptor gene. There is evidence implicating endoplasmic reticulum stress in the development and progression of neurodegenerative disease, including polyglutamine disorders such as Huntington's disease and in motor neuron disease, where cellular stress disrupts functioning of the endoplasmic reticulum, leading to induction of the unfolded protein response. We examined whether endoplasmic reticulum stress is also involved in the pathogenesis of spinal and bulbar muscular atrophy. Spinal and bulbar muscular atrophy mice that carry 100 pathogenic polyglutamine repeats in the androgen receptor, and develop a late-onset neuromuscular phenotype with motor neuron degeneration, were studied. We observed a disturbance in endoplasmic reticulum-associated calcium homeostasis in cultured embryonic motor neurons from spinal and bulbar muscular atrophy mice, which was accompanied by increased endoplasmic reticulum stress. Furthermore, pharmacological inhibition of endoplasmic reticulum stress reduced the endoplasmic reticulum-associated cell death pathway. Examination of spinal cord motor neurons of pathogenic mice at different disease stages revealed elevated expression of markers for endoplasmic reticulum stress, confirming an increase in this stress response in vivo. Importantly, the most significant increase was detected presymptomatically, suggesting that endoplasmic reticulum stress may play an early and possibly causal role in disease pathogenesis. Our results therefore indicate that the endoplasmic reticulum stress pathway could potentially be a therapeutic target for spinal and bulbar muscular atrophy and related polyglutamine diseases.

Indexed as

Age FactorsAndrogensAnimalsAnterior Horn CellsApoptosisCells, CulturedDihydrotestosteroneDisease Models, AnimalEmbryo, MammalianEndoplasmic ReticulumEndoplasmic Reticulum StressEnzyme InhibitorsFemaleGene Expression RegulationMaleMiceAndrogensDihydrotestosteroneEnzyme InhibitorsSarcoplasmic Reticulum Calcium-Transporting ATPasesThapsigargincalciumendoplasmic reticulum stressmotor neuron diseasepolyglutamine expansionsSBMA

Identifiers

PMID24898351
PMCPMC4065020
OpenAlexW2131313048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.